The Current Ratio as of September 2024 (TTM) for IntelGenx Technologies Corp. (IGXT) is 0.13

According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 0.13. This represents a change of -68.67% compared to the average of 0.40 of the last 4 quarters.

IntelGenx Technologies Corp. (IGXT) Historical Current Ratio (quarterly & annually)

How has IGXT Current Ratio performed in the past?

The mean historical Current Ratio of IntelGenx Technologies Corp. over the last ten years is 1.93. The current 0.13 Current Ratio has changed 550.28% with respect to the historical average. Over the past ten years (40 quarters), IGXT's Current Ratio was at its highest in in the June 2014 quarter at 8.88. The Current Ratio was at its lowest in in the March 2024 quarter at 0.13.

IntelGenx Technologies Corp. (IGXT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IntelGenx Technologies Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IntelGenx Technologies Corp. (IGXT) Average Current Ratio

How has IGXT Current Ratio performed in the past?

The current Current Ratio of IntelGenx Technologies Corp. (IGXT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IntelGenx Technologies Corp. (IGXT) Current Ratio vs. Peers

How is IGXT’s Current Ratio compared to its peers?

IntelGenx Technologies Corp.’s Current Ratio is less than Adynxx, Inc. (0), greater than NLS Pharmaceutics AG (0), less than Ascletis Pharma Inc. (0.23), less than Sirona Biochem Corp. (16.58), less than LianBio (0.34), less than Fennec Pharmaceuticals Inc. (0), less than Larimar Therapeutics, Inc. (10.06), less than Verrica Pharmaceuticals Inc. (8.02), less than Homology Medicines, Inc. (10.93), less than Candel Therapeutics, Inc. (2.36), less than PMV Pharmaceuticals, Inc. (4.19), less than Acurx Pharmaceuticals, Inc. (1.62), less than Monopar Therapeutics Inc. (19.22), less than Enochian Biosciences, Inc. (2.09), less than Connect Biopharma Holdings Limited (6.59), greater than Acumen Pharmaceuticals, Inc. (0.06), less than Eton Pharmaceuticals, Inc. (4.99), less than Nuvation Bio Inc. (17.37), less than Eledon Pharmaceuticals, Inc. (1.40), less than null (11.49), less than null (14.48),

Build a custom stock screener for IntelGenx Technologies Corp. (IGXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IntelGenx Technologies Corp. (IGXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.